Michael Rubin You might not see Michael Rubin, the CEO of the brand Fanatics, on your social media feed
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications primarily prescribed for type 2 diabetes management and, more recently, for chronic weight management
Discussion Our study identified presumptive vagal axons closely associated with a small number of L-cells, initially suggesting apparent contacts at low magnification
If you're already on a GLP-1 and haven't considered creatine, it's worth the conversation with your doctorespecially if muscle loss, fatigue, or mental fog are part of your experience
More importantly, the hazard ratio for major adverse cardiovascular events (including cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina) for the pooled tirzepatide groups versus glargine was 0.74 (95% CI 0.511.08), suggesting no increased cardiovascular risk with tirzepatide compared to insulin glargine
"The most common ones that we found in our sample were things like nausea and vomiting and constipation, and these line up pretty well with what clinical trials have found," he said
